Assistant Professor
Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania, United States
Astra Zeneca (Consultant/Advisory Board)AstraZeneca (Consultant/Advisory Board)AstraZeneca (Inst) (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)AstraZeneca (Inst) (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Bluebird Bio (Ownership Interest includes stock, stock options, patent or other intellectual property)Blueprint Pharmaceuticals (Consultant/Advisory Board)Boehringer Ingelheim (Consultant/Advisory Board)Bristol Myers Squibb (Consultant/Advisory Board)Eli Lilly (Inst) (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Gilead Sciences (Ownership Interest includes stock, stock options, patent or other intellectual property)Ikena (Consultant/Advisory Board)Janssen (Consultant/Advisory Board)Johnson & Johnson (Ownership Interest includes stock, stock options, patent or other intellectual property)Merck (Ownership Interest includes stock, stock options, patent or other intellectual property)Merck (Inst) (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Novocure (Consultant/Advisory Board)Pfizer (Ownership Interest includes stock, stock options, patent or other intellectual property)Portola Pharmaceuticals (Ownership Interest includes stock, stock options, patent or other intellectual property)Takeda (Consultant/Advisory Board)
Sunday, August 28, 2022
9:30 AM – 9:45 AM CEST